Section 20-1-150 Marking or imprinting of drug products in finished solid oral dosage forms required. No drug product in finished solid oral dosage form for which a prescription is required by federal law may be manufactured or commercially distributed within this state unless it has clearly and prominently marked or imprinted on it an individual […]
Section 20-1-151 Descriptive material to be furnished upon request. Manufacturers or distributors shall make available on request to the State Board of Health descriptive material which will identify each current imprint used by the manufacturer or distributor. (Acts 1981, No. 81-389, p. 595, §2.)
Section 20-1-152 Department of Health to promulgate rules. The Department of Health shall promulgate rules for implementing the provisions of this article. (Acts 1981, No. 81-389, p. 595, §3.)
Section 20-1-153 Exemptions from imprinting requirement. The State Board of Health may exempt drug products from the requirements of Section 20-1-150 on the grounds that imprinting is not feasible because of size, texture, or other unique characteristics. (Acts 1981, No. 81-389, p. 595, §4.)
Section 20-1-154 Exemptions for drugs compounded by a pharmacist. The provisions of this article shall not apply to drug products compounded by a pharmacist licensed under Alabama law, in a pharmacy operating under a permit issued by the Alabama Board of Pharmacy. (Acts 1981, No. 81-389, p. 595, §5.)
